Autophagy Fasting: Cardio Benefits Revealed

Introduction

A 2023 review in Current Hypertension Reports connects the dots between fasting, cellular housekeeping, and heart health. Researchers from the Universidad Nacional de Cuyo argue that the cardioprotective benefits of calorie restriction and certain diabetes drugs stem from a shared biological trigger: stimulating the body’s internal recycling system, autophagy.

Metabolic Syndrome Clogs the Cellular Machinery

The review, led by Walter Manucha’s team in Argentina, explains how conditions like metabolic syndrome create a “perfect storm” for heart disease. Constant high blood sugar and insulin resistance overwork the mitochondria, the cell’s power plants. This generates excessive reactive oxygen species (ROS), a type of oxidative stress that damages cellular structures.

Compounding the problem, a hyperactive renin-angiotensin system elevates a hormone called angiotensin II. This further fuels inflammation and fibrosis, the scarring of heart tissue. At the core of this dysfunction is a drop in sirtuin activity. Sirtuins are a family of proteins, including the well-known SIRT1, that function as guardians of metabolic health and genomic stability. Their decline impairs the cell’s ability to respond adaptively to stress.

Sirtuins: The Molecular Switches Turned on by Fasting

The body’s response to a lack of food provides a powerful countermeasure. Fasting and low-energy states activate a master energy sensor called AMPK. This, in turn, stimulates sirtuin production. Elevated sirtuins initiate a cascade of protective events. They help activate HIF-1β, a protein that aids adaptation to low oxygen, and promote a metabolic shift toward ketosis, where the body burns fat for fuel.

Most importantly, this sirtuin-driven program activates autophagy and its targeted form for mitochondria, mitophagy. Think of autophagy as a cellular garbage collection and recycling service. It identifies damaged proteins and worn-out organelles, like smoky mitochondria, envelopes them, and breaks them down for parts. For the heart, this cleansing is vital. It removes the source of oxidative stress, dampens inflammation, and prevents the pathological remodeling that leads to heart failure.

How Diabetes Drugs Mimic a Fasting State

The research presents a compelling observation: a class of diabetes drugs, sodium-glucose co-transporter 2 (SGLT-2) inhibitors like empagliflozin, appear to copy this fasting biology. Large clinical trials unexpectedly showed these drugs significantly reduce heart failure hospitalizations. The Argentine researchers propose the mechanism is pharmacological mimicry of fasting.

“SGLT-2 inhibitors enhance the level of at least four sirtuins, some located in the mitochondria,” they write. By blocking glucose reabsorption in the kidneys, these drugs cause the body to excrete sugar and, to a degree, mimic a low-energy state. This is thought to boost sirtuins, reduce angiotensin II-driven damage, and promote autophagy. The result is cleaner, more efficient heart cells with less oxidative stress and fibrosis. This connection suggests the drugs’ benefit is less about blood sugar control and more about triggering fundamental longevity-associated pathways.

Activating Autophagy for Heart and Healthspan

This mechanistic link between fasting, sirtuins, and cellular cleaning provides a clear rationale for lifestyle and pharmacological strategies. Intermittent fasting or time-restricted eating patterns may confer protection by periodically activating this sirtuin-autophagy axis. Certain natural compounds are also being studied for their ability to induce autophagy. For instance, spermidine, found in foods like wheat germ and aged cheese, has been shown to boost autophagy independently of fasting.

The findings also underscore the importance of maintaining mitochondrial health and sirtuin activity as we age. Strategies aimed at supporting cellular NAD+ levels, a critical co-factor for sirtuins, such as with precursors like NMN or NR, are a major focus of anti-aging research. It’s important to note that much of this evidence is pre-clinical or based on mechanistic reviews; large, long-term human trials on fasting for cardiac outcomes are still needed. Furthermore, SGLT-2 inhibitors are prescription medications with specific indications and are not a general anti-aging supplement.

Conclusion

The research illustrates a fundamental pathway: energy stress (from fasting) → sirtuin activation → enhanced autophagy → cellular cleanup and protection. This pathway, which can be impaired by metabolic disease, offers a unifying explanation for the benefits of calorie restriction and points toward new therapeutic targets for preserving heart function and overall healthspan.

Sources:
https://pubmed.ncbi.nlm.nih.gov/37052810/
https://pubmed.ncbi.nlm.nih.gov/34713882/
https://pubmed.ncbi.nlm.nih.gov/31877888/